Join to View Full Profile
1515 Holcombe BlvdUnit 450Houston, TX 77030
Phone+1 713-792-3626
Fax+1 713-794-1934
Dr. Conley is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Anthony Conley is an oncology specialist based in Houston, TX, with a subspecialty in sarcoma. He completed his medical education at the University of Texas Medical Branch School of Medicine in 2004, followed by a residency in Internal Medicine and a fellowship in Hematology and Medical Oncology at the University of Texas Health Science Center at Houston and MD Anderson Cancer Center. He currently holds a position as an Associate Professor at UT MD Anderson Cancer Center. His expertise includes gastrointestinal stromal tumors and various sarcoma subtypes, and he has published several studies in prominent journals. Dr. Conley has been involved in multiple clinical trials focusing on treatments for sarcomas and other solid tumors. He received the Young Investigator Award from ASCO.
Education & Training
University of Texas Health Science Center at Houston/M D Anderson Cancer CenterFellowship, Hematology and Medical Oncology, 2007 - 2010- University of Texas Health Science Center at HoustonResidency, Internal Medicine, 2004 - 2007
University of Texas Medical Branch School of MedicineClass of 2004
Certifications & Licensure
FL State Medical License 2021 - Present
AZ State Medical License 2025 - 2027
TN State Medical License 2025 - 2027
GA State Medical License 2025 - 2026
LA State Medical License 2025 - 2026
MS State Medical License 2025 - 2026
OK State Medical License 2025 - 2026
American Board of Internal Medicine Medical Oncology- Join now to see all
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification ClinicStation, UT MD Anderson Cancer Center, 2013, 2015
- CMS Meaningful Use Stage 1 Certification ClinicStation, UT MD Anderson Cancer Center, 2013, 2015
- Young Investigator Award ASCO
Clinical Trials
- Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions) Start of enrollment: 2015 Nov 19
- QUILT-3.031: AMG 337 in Subjects With Advanced or Metastatic Clear Cell Sarcoma Start of enrollment: 2018 Aug 29
- Testing Atezolizumab Alone or Atezolizumab Plus Bevacizumab in People With Advanced Alveolar Soft Part Sarcoma Start of enrollment: 2017 Apr 25
Publications & Presentations
PubMed
- 3 citationsPhase Ib Study of Pembrolizumab in Combination with Intratumoral Injection of Clostridium novyi-NT in Patients with Advanced Solid Tumors.Blessie Elizabeth Nelson, Filip Janku, Siqing Fu, Ecaterina E Dumbrava, David S Hong
Clinical Cancer Research. 2025-09-15 - 3 citationsPhase I Study of the Mutant IDH1 Inhibitor Ivosidenib: Long-term Safety and Clinical Activity in Patients with Conventional Chondrosarcoma.William D Tap, Gregory M Cote, Howard Burris, Lia Gore, Anthony Elias
Clinical Cancer Research. 2025-06-03 - 3 citationsTFCP2 Fusion-Positive Rhabdomyosarcomas: A Report of 10 Cases and a Review of the Literature.Madison P Ginn, Ryan A Denu, Davis R Ingram, Khalida M Wani, Alexander J Lazar
Cancers. 2025-04-25
Journal Articles
- Cytokines Produced by Dendritic Cells Administered Intratumorally Correlate with Clinical Outcome in Patients with Diverse CancersRavi Murthy, Robert S Benjamin, Anthony P Conley, Chitra Hosing, David S Hong, Aung Naing, Clinical Cancer Research
Press Mentions
Surviving Sarcoma Took a Different Treatment Route Than I ExpectedJune 26th, 2018- Young Desmoid Tumor Survivor Gets Life Back with 17-Hour SurgeryJune 6th, 2017
MD Anderson Research Highlights for October 4, 2023October 5th, 2023
Committees
- Member, Connective Tissue Oncology Society (CTOS) Outreach Committee 2022 - Present
- Vice Chair, 09-2025 to present, Medical Practice Committee, MDACC, Houston, TX 2019 - Present
- Member, Institutional Review Board (IRB) 2, MDACC, Houston, TX 2022 - 2024
- Faculty Senator, Faculty Senate, MDACC, Houston, TX 2021 - 2025
Professional Memberships
- Member
- Member
- Connective Tissue Oncology SocietyMember
- European Society for Medical OncologyMember
- Society for Immunotherapy in CancerMember
Other Languages
- Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
